Assam University Achieves Milestone with Anti-HIV Patent through Organic Photosynthesis

The Department of Chemistry at Assam University, Silchar, has attained a groundbreaking academic milestone by securing its first patent. The patent (number 454199), titled “MESO-TRIS-CARBOXYPHENYLPORPHYRIN FULLERENE ADDUCTS AS ANTI-HIV AGENTS,” is the result of innovative research on organic photosynthesis, specifically an anti-HIV agent developed by Dr. Devashish Sengupta and his team in collaboration with the Department of Life Sciences and Biotechnology at South Asian University (SAU) in New Delhi.

Dr. Sengupta explained that their research focuses on the use of amphiphilic non-cationic fullerene porphyrin dyads in inhibiting HIV-1 under photodynamic conditions, potentially revolutionizing HIV treatment. The team also devised a scalable method for synthesizing water-soluble fullerene-meso-tris-carboxyphenyl porphyrin dyads, which demonstrated effectiveness in hindering the entry and production of HIV-1 subtypes B and C.

Dr. Sengupta highlighted the broader implications of their work, suggesting a synergistic medicine that could address both HIV and cancer among patients, reducing the need for prolonged drug cocktails. The patent marks a significant achievement for Assam University, with over 16 patents awarded in the last three years, showcasing a commitment to intellectual property protection. Prof. Rajive Mohan Pant, the vice-chancellor, praised Dr. Sengupta and his team, acknowledging the development as a major strength for the university.